Literature DB >> 33227288

Clinical features of mtDNA-related syndromes in adulthood.

V Montano1, F Gruosso1, C Simoncini1, G Siciliano1, M Mancuso2.   

Abstract

Mitochondrial diseases are the most common inheritable metabolic diseases, due to defects in oxidative phosphorylation. They are caused by mutations of nuclear or mitochondrial DNA in genes involved in mitochondrial function. The peculiarity of "mitochondrial DNA genetics rules" in part explains the marked phenotypic variability, the complexity of genotype-phenotype correlations and the challenge of genetic counseling. The new massive genetic sequencing technologies have changed the diagnostic approach, enhancing mitochondrial DNA-related syndromes diagnosis and often avoiding the need of a tissue biopsy. Here we present the most common phenotypes associated with a mitochondrial DNA mutation with the recent advances in diagnosis and in therapeutic perspectives.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MELAS; MERRF; Mitochondrial disorders; Primary mitochondrial myopathy

Year:  2020        PMID: 33227288     DOI: 10.1016/j.abb.2020.108689

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  Mitochondrial base editor induces substantial nuclear off-target mutations.

Authors:  Zhixin Lei; Haowei Meng; Lulu Liu; Huanan Zhao; Xichen Rao; Yongchang Yan; Hao Wu; Min Liu; Aibin He; Chengqi Yi
Journal:  Nature       Date:  2022-05-12       Impact factor: 49.962

Review 2.  Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System.

Authors:  Masaru Tanaka; Ágnes Szabó; Eleonóra Spekker; Helga Polyák; Fanni Tóth; László Vécsei
Journal:  Cells       Date:  2022-08-21       Impact factor: 7.666

Review 3.  Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS.

Authors:  Syuichi Tetsuka; Tomoko Ogawa; Ritsuo Hashimoto; Hiroyuki Kato
Journal:  Metab Brain Dis       Date:  2021-06-12       Impact factor: 3.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.